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The composition and morphology of nanocrystals in urines of healthy persons and lithogenic patients were comparatively
investigated by means of X-ray diﬀraction (XRD) and transmission electron microscopy (TEM). It was shown that the main
composition of urinary nanocrystals in healthy persons were calcium oxalate dihydrate (COD), uric acid, and ammonium
magnesium phosphate (struvite). However, the main compositions of urinary nanocrystals in lithogenic patients were struvite,
β-tricalcium phosphate, uric acid, COD, and calcium oxalate monohydrate (COM). According to the XRD data, the size of
nanocrystals was calculated to be 23 ∼ 72nm in healthy urine and 12 ∼ 118nm in lithogenic urine by Scherer formula. TEM
results showed that the nanocrystals in healthy urine were dispersive and uniform with a mean size of about 38nm. In contrast,
the nanocrystals in lithogenic urine were much aggregated with a mean size of about 55nm. The results in this work indicated that
the urinary stone formation may be prevented by diminishing the aggregation and the size diﬀerentiation of urinary nanocrystals
by physical or chemical methods.
Copyright © 2009 Bao-Song Gui et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Urolithiasis, which occurs in 1∼20% in Asia, 5∼9% in
Europe, and approximately 13% in North America, is a
worldwide common and frequently occurring disease [1, 2].
Especially, it has high incidence in adult men among 20∼40
years old who have large amount of exercise. The main com-
ponents of urinary stones include calcium oxalate, calcium
phosphate, uric acid, magnesium ammonium phosphate
(struvite), and cystines. Approximately 80% of stones are
calcicinwhichcalciumoxalateisthemaincomponent[2–5].
Theﬁrststepofurinarystoneformationisthenucleation
of particles in supersaturated urine. Then the formed nuclei
(generally less than 10nm) grow or/and aggregate to a
pathologicalsize(severaltensmicron).Afterthesecrystallites
are retained on the urinary tract (free-particle theory)
or ﬁxed by the urinary tract organization (ﬁxed-particle
theory), urinary stones ultimately formed [6].
According to the chemical properties, urinary stone can
be classiﬁed into acidic stones (such as uric acid, cystine),
alkaline stones (such as struvite), and neutral stones (such
as calcium oxalate, calcium phosphate). However, clinical
practices neither can be predicted before stone formation
nor can be individually treated by taking diﬀerent medicine
and diﬀerent treatment methods for diﬀerent types of
urinary stones. Thus it results in a low treatment ratio.
Thereby, if the occurrence of urinary stones can be predicted
or the type of stones can be estimated before treatment
by the determination of urinary composition and urinary
nanocrystals, it will provide evidence for a suitable remedy
and personalized treatment in clinic.
XRD has advantages of reliability in qualitative analysis
and accuracy in quantitative analysis. It operates simply and
has a high sensitivity. Based on XRD diﬀraction data, the
multicomponents in a sample can be measured simultane-
ously, and the approximate size of the nanoparticles can also
be calculated by means of Scherer formula. For example,
Chen et al. [7] had calculated the size of nanosilver (Ag)
to be 7–22nm, and Satyanarayana et al. [8]h a dc a l c u l a t e d
the size of nanocuprous oxide (Cu2O) to be 11nm by
Scherer formula. Transmission electron microscopy (TEM),
with larger ampliﬁcation and high resolution, is commonly2 Bioinorganic Chemistry and Applications
Table 1: Urinary stone risk proﬁle in lithogenic patients and in normal subjects.
Urine parameter Lithogenic patients (n = 16) Normal subjects (n = 17)
Volume, L 1721 ±429 1202 ±354
pH 6.32 ±0.35 6.02 ±0.32
Calcium, mmol/L 5.51 ±1.32 5.71 ±2.11
Oxalate, mmol/L 0.53 ±0.09 0.29 ±0.05
Citrate, mmol/L 1.71 ±0.94 2.32 ±0.85
Phosphorus, mmol/L 15.3 ±5.81 6 .1 ±4.7
used in the observation of nanomaterials. The examination
of urinary nanocrystals by means of TEM can help us to
understand the relationship between these nanocrystals and
formation of various types of urinary stones.
Based on the discussed above, the composition, size,
morphology, and aggregation of the nanocrystals of less
than 100nm in healthy urines and in lithogenic urines are
comparatively investigated by XRD and TEM. We hope it
would provide enlightenment on diagnosing and treating
urinary stone.
2.ExperimentalDetails
2.1. Materials. Anhydrous alcohol and sodium azide were
reagent-grade chemicals. All the glasswares were cleaned
with the ultrapure water from the Millipore-Q system; the
resistancewas18.2MΩcm.Thefreshmorningurinesamples
were collected from both patients who had urinary stones
and healthy persons with no prior history of urinary stones.
2.2. Apparatus. TEM was carried out by PHILIPS TECNAI-
10 transmission electron microscope at an operating voltage
of 100kV. X-ray diﬀraction (XRD) results were recorded on
a D/max 2400
X-ray diﬀractometer (Rigaku, Japan) used graphite
monochromator, Ni-ﬁltered CuKα radiation (λ =
0.15406nm), and a scanning rate of 0.02◦s−1 at 40kV,
30mA.Thedivergenceandscatteringslitwas1o fortherange
5◦ < 2θ<60
◦. Urinary stones and urinary crystals were
identiﬁed according [9]. Magnesium ammonium phosphate
monohydrate (MgNH4PO4 · H2O) and hexahydrate
(MgNH4PO4 · 6H2O, struvite) were compared with
ASTM card number 20-0663 and 77-2303, respectively.
Octacalcium phosphate (Ca8H2(PO4)6 · 5H2O), calcium
phosphate (Ca3(PO4)2, CaP), and hydroxylapatite (HAP)
were compared with the number 44-0778, 32-176, and
09-0432, respectively. Uric acid (UA), calcium oxalate
monohydrate (COM), and dihydrate (COD) were compared
with the number 09-0432, 20-231, and 17-541, respectively.
2.3. Clinical Data and Test Method.
2.3.1. Clinical Data. The participants in the study included
sixteen lithogenic patients (9 men and 7 women) with a
mean age of 44.7 years (23∼70 years old) and seventeen
random selected healthy human (8 men and 9 women) with
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Figure 1: XRD patterns of three representative urinary stones (∗:
COM, ∗∗:C O D ,

:H A P ,:C a 3(PO4)2).
no prior history of urinary stone with a mean age of 38.6
years (22∼53 years old). The urinary stones were collected
after surgery, cleared by double distilled water, and put in a
no dust incubator about 50◦C tomake dry, thengrinded into
powderbyagatemortarforXRDandFT-IRcharacterization.
The results showed that the main compositions of these
stones were CaOxa or CaOxa–CaP. The XRD patterns of
three representative urinary stones were shown in Figure 1.
The fresh morning urine from the patients with CaOxa
stone or CaOxa–CaP stone was collected from 06:00 to 08:00
AM. without being submitted to special diets. Peoples who
provided urine samples did not eat any food from 9:00 PM.
last night to acquisition time of their urine samples. Table 1
showed the urinary stone risk proﬁle in urine of lithogenic
patients and normal subjects.
2.3.2. Test Method. After the fresh morning urine was
collected, 2% (weight/volume ratio) NaN3 solution (urine :
NaN3 = 100 : 1 in volume) was immediately added into
the urine as antiseptic. Then the urine was added anhydrous
alcohol(urine:anhydrousalcohol = 3:2inv olume)andwas
stoodforhalfhourtomaketheurinaryproteindenaturation.
The celldebris and the denatured protein precipitations were
ﬁltered out using a microporous membrane with the pore
size of 1.2μm. It was shown that the ﬁltration with a 1.2μm
microporous membrane had signiﬁcant inﬂuence on theBioinorganic Chemistry and Applications 3
Table 2: Main diﬀraction peaks (d value) and corresponding crystal faces of urinary nanocrystals.
Nanocrystal in urine d value (crystal plane) ASTM card [9]
NH4MgPO4 ·H2O 8.79(010), 2.80(121), 4.73(110), 4.20(011), 3.24(012) 36-1491
NH4MgPO4 ·6H2O 5.60(020), 3.66(121), 3.29(130), 2.80(040), 2.01(151) 15-762
C5H4N4O3 4.91(210), 3.86(211), 3.19(021), 3.10(121) 31-1982
β-Ca3(PO4)2 4.06(024), 4.00(116), 2.88(217), 2.20(404), 1.81(210) 9-169
CaC2O4 ·H2O(COM) 5.93(101), 3.65(020), 2.97(202), 2.84(121), 1.98(303) 20-231
CaC2O4 ·2H2O(COD) 6.18(200), 4.42(211), 3.91(310), 2.78(411), 2.34(501), 17-541
2.24(213), 2.00(323), 1.62(730)
particles larger than 400nm and exerted little inﬂuence on
the small particles with the size less than 100nm in the two
kinds of urines.
The ﬁltrate was added on a copper mesh for TEM
detection and on clean glass tablet for XRD characterization
simultaneously. For the former, the copper mesh was put in
a desiccators, and for the latter, the glass tablet was put in
a no dust incubatorat at 50◦C for 4 hours to make urine
evaporation.
3. Results andDiscussion
3.1. Diﬀerentiation of Components of Urinary Nanocrystals
in Lithogenic Urine and in Healthy Urine. XRD was used to
investigate the composition of urinary nanocrystals of 16
lithogenic patients and 17 healthy persons. Figures 2 and
3 showed the representative XRD patterns of the urinary
nanocrystals in three healthy persons and in three lithogenic
patients, respectively. Compared with the standard diagrams
(see Table 2)[ 9], the main peaks in Figure 2(a) were assigned
to the (110) crystal plane of MgNH4PO4 · H2O, the (021)
plane of uric acid (411), (501), and (730) planes of calcium
oxalate dihydrate (COD). The main peaks in Figure 2(b)
were assigned to the (211) plane of uric acid, the (121) plane
of MgNH4PO4 · 6H2O, and the (411) and (323) planes of
CODcrystals.ThemainpeaksinFigure 2(c)wereassignedto
the (310), (411), and (323) planes of COD crystal. That is, all
the three urinary nanocrystals in healthy persons contained
COD crystals.
In the three XRD patterns of urinary nanocrystals
of lithogenic patients (see Figure 3), the main peaks in
Figure 3(a)were,respectively,assignedtothe(024)and(404)
crystalplanes ofβ-Ca3(PO4)2 and the(040) and(151) planes
of MgNH4PO4 · 6H2O. The main peaks in Figure 3(b) were
assignedtothe(130)and(040)planesofMgNH4PO4·6H2O,
the(121)planeofCOM,andthe(210)planeofβ-Ca3(PO4)2,
respectively. In Figure 3(c) the main peaks were, respectively,
assigned to the (211) and (021) planes of uric acid, and the
(411) and (323) planes of COD crystals.
All the XRD results showed that the urinary nanocrystals
were mainly COD, uric acid and magnesium ammonium
phosphate in healthy urine (see Figure 2) and were mainly
magnesium ammonium phosphate, β-tricalcium phosphate,
COD, and COM in lithogenic urine (see Figure 3).
It could be seen that the peak intensities of struvite
crystals in urine of lithogenic patients (see Figure 3(a))w e r e
stronger than those in urine of healthy persons (see Figures
2(a)-2(b)). It was attributed to that the concentration of
citrate in health urine (2.32 ± 0.85mmol/L) was higher than
that in lithogenic urine (1.71 ± 0.94mmol/L) as shown in
Table 1 and as reported by Biyani et al. [10]. Citrate could
form complexes with phosphoric acid or phosphate in urine,
therefore inhibited struvite precipitation [11].
It could also be seen that the peak intensities of (411)
and (323) crystal planes of COD crystals in urine of healthy
persons (see Figures 2(a)-2(c)) were stronger than those in
urineoflithogenicpatient(seeFigure 3(c)).Sincethediﬀrac-
tion peak intensity was positively related with the number
of crystals, it indicated that the amount of COD crystals in
healthy urine was more than that in lithogenic urine.
The diﬀerentiation of COD crystals in the two kinds of
urine was attributed to the diﬀerence of urinary inhibitors.
TheseurinaryinhibitorscouldinhibittheformationofCOM
crystals and induce the growth of COD crystals [12–14].
One kind of these inhibitors was small molecule substance
such as citrate, glutamic acid, pyrophosphate, magnesium,
and the other kind was the urinary macromolecules such
as glycosaminoglycans (GAGs), uromucoid, prothrombin
fragment F1 (UPTF1), Tamm-Horsfall protein, nephrocalcin
(NC), osteopontin (OPN), and polyribonucleotide [10,
15, 16]. These substances, especially the urinary macro-
molecules, had much negative charges and were inclined to
be the nucleated nidus for urinary stone such as CaOxa stone
[17, 18]. For the bipyramidal COD crystals, there were only
high-density charged locate at the two vertexes in which the
Oxa2− ions were outstanding and negatively charged. How-
ever, the surfaces of COM crystals were positively charged
[19]. So the negatively charged urinary macromolecules
preferentiallycombinedwiththefaceofCOMcrystals,which
is positively charged [20–22] and blocked the growth sites
on the surface of COM. It increased the negative value
of Zeta potential on the surface of COM crystals and led
to a stronger repellent action among the nanocrystals in
urine. Thus, the nucleation and growth of COM crystals in
healthy urine were inhibited. However, in urine of lithogenic
patients,eithertheconcentrationofmacromoleculeswasless
or their activity was lower. For example, the concentration
of GAGs in urine of healthy human was about 8.80 ±
1.92mg/L; however, it decreased to about 6.08 ± 1.39mg/L
in lithogenic urine. Therefore, the interaction between the
urinary macromolecules and nanocrystals was weaker in
urine of lithogenic patients. Thus less COD crystals were4 Bioinorganic Chemistry and Applications
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Figure 2: XRD patterns of typical urinary crystals of three health
persons (H1, H2, H3). (∗:C O M ,∗∗:C O D ,•: uric acid, :
MgNH4PO4 ·H2O, :M g N H 4PO4 ·6H2O).
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Figure 3: XRD patterns of typical urinary crystals of three
lithogenic patients (L1, L2, L3). (∗:C O M ,∗∗:C O D ,•: uric acid,
:M g N H 4PO4 ·6H2O, : β-Ca3(PO4)2).Bioinorganic Chemistry and Applications 5
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Figure 4: TEM images of typical urinary nanocrystals of two health persons (a), (b) and two lithogenic patients (c), (d). The bar is 100nm.
induced. That is, calcium oxalate mainly precipitated as
COM crystals in the urine of lithogenic patients. It made the
intensityofdiﬀractionpeaksofCODcrystalsinhealthyurine
generally be stronger than that in lithogenic urine.
3.2. Diﬀerentiation of Morphology and Aggregation of Urinary
Nanocrystals in Lithogenic Urine and in Healthy Urine.
Figure 4 showed the TEM images of representative urinary
nanocrystals of healthy persons and lithogenic patients. The
urinary nanocrystals of healthy persons were well dispersed
and uniform with a size distribution between 15 nm and 60
nm (see Figures 4(a), 4(b)). In contrast, the nanocrystals of
lithogenic patients were not uniform with a size distribution
ranging from 10 nm to more than 100 nm (see Figures 4(c),
4(d)). In addition, more aggregated nanocrystals were found
in lithogenic urine.
Based on the XRD diﬀraction data, not only could
the components of samples be measured, but also the
approximate size of the nanoparticles could be calculated
using Scherer formula [7, 8, 23] as shown in (1):
L =
Kλ
cosθ ·Δ(2θ)
,( 1 )
where L was the size of the nanoparticles, K is constant and
is dependent on crystallite shape (0.89), λ was the X-ray
wavelength (λ = 1.5418 ˚ A in this experiment), (2θ)w a s
the radian value of fwhm (full width at half-max), and θ was
the Bragg angle. For example, in Figure 2(a), the strongest
characteristic diﬀraction peak of COD crystals was the (411)
face with a d value of 0.279 nm, the corresponding 2θ =
32.00
◦ and θ = 16.00
◦. The maximal intensity of this peak
was 6689.2, so the height at half-max was 3344.6, and the6 Bioinorganic Chemistry and Applications
Table 3: Sizes of urinary nanocrystals in three healthy persons (H) and in three lithogenic patients (L) calculated using scherer formula
(nm).
Urine nanocrystals H1 H2 H3 L1 L2 L3
COD 41∼47 37∼49 45∼51 — — 36∼45
s t r u v i t e 3 24 0————
uric acid 23 72 — — — 27∼65
β-Ca3(PO4)2 ——— 2 9 ∼45 118 —
struvite — — — 51 12∼39 —
Supersaturation
(calcium, oxalate etc.)
Crystallization
inhibitors/modulators
Crystal erosion to papillary
surface, nidus formation
Crystal nucleus formation
Crystal growth
Crystal aggregation
Growth to stone
Adhesion to injured cell
Figure 5: Schematic diagram of urinary stone formation.
corresponding 2θ values at the two points of half-max were
32.09◦ and 31.86◦,r e s p e c t i v e l y .T h a tw a s (2θ)(32.09
◦ −
31.86
◦) · π/180
◦. By substituting these values into (1), we
could ﬁgure out that the size of COD nanocrystals L(COD)
was 41nm. By means of the same method, we could also
ﬁgure out the size of the other nanocrystals in healthy
urine. For example, for the sample H1 in Figure 2(a), L
(MgNH4PO4 · H2O) = 32nm (110 face), L(uric acid) = 23
nm (021 face), and L(COD) = 41 ∼ 47nm ((411), (501),
and (730) faces). For the sample H2 in Figure 2(b), L(COD)
= 37 ∼ 49nm ((411) and (323) faces), L(uric acid) = 72
nm(211face),L(struvite) =40nm(121face).Forthesample
H3 (Figure 2(c)), L(COD) = 45 ∼ 51 nm ((310), (411), and
(323) faces) (see Table 3).
For the urinary nanocrystals in lithogenic urine sample
L1 (Figure 3(a)), it could be calculated that the size of nano-
β-Ca3(PO4)2 (L (β-Ca3(PO4)2)) was 29 ∼ 45 nm ((024) and
(404)faces);L(MgNH4PO4·H2O) = 51nm((040)and(151)
faces). For sample L2 (Figure 3(b)), L (β-Ca3(PO4)2) = 118
nm ((210) face), and L(struvite) = 12 ∼ 39 nm ((130) and
(040)faces).ForsampleL3(Figure 3(c)),L(uricacid)= 27 ∼
65 nm ((211) and (021) faces), and L(COD) = 36∼45nm
((411) and (323) faces).
That is, the size of nanocrystals in the healthy persons
urine ranged from 23nm to 72nm, and those in lithogenic
patients urine ranged from 12nm to 118nm. The results
obtained from Scherer formula were nearly consistent with
those observed from the TEM method.
Since there was a diﬀerent ratio of volume to surface
area for the particles with diﬀerent size, it led to the
diﬀerence in their solubility. According to the mechanism of
Ostwald ripening [24], when solid particles were dispersed
in their own saturated solution, there was a tendency that
the small-size particles be dissolved and the solute be
deposited subsequently on the large-size particles. Therefore,
the uneven distribution of nanoparticles in lithogenic urine
made the small-size crystals disappeared and the large-
size crystals grew; thus these urine samples were unstable.
However, the nanoparticles in healthy urine were uniform. It
led to a weak interaction and a small diﬀerence of the surface
free energy between particles; thus the driving force for these
nanoparticles to aggregate diminished and ﬁnally these urine
samples were stable.
Althoughtheformationofurinarystonescorrelatedwith
many factors, it necessarily went through the following pro-
cesses: the formation of crystal nucleus in urine, the growth
and/or aggregation of the crystallites, and the adhesion of
crystallites on renal epithelial cell, as shown in Figure 5.
Accordingtothecalculationresultsofcrystalgrowthrateand
ﬂow rate of urine through tubule lumen, a single crystallite
could not block the tubule lumen badly when it passed the
nephron. Only after the urine crystallites had combined with
other substances such as the cell debris in urine, the aggre-
gated crystallites were formed, then the larger size of crystals
could block the nephron, and ﬁnally stone formed [25].
Since the growth, aggregation and the ﬁnal formation of
urinary stones were apparently aﬀected by the components,
size, and uniformity of urinary nanocrystals, therefore,
urinary stone formation may be prevented by diminishing
the size diﬀerentiation and the aggregation of nanocrystals
in urine through physical or chemical methods. The investi-
gatation about the existing state of urinary nanocrystals and
the detection of the components and properties of nanocrys-
tals in urine would be beneﬁcial to ﬁnd out the connection
between stone formation and urinary nanocrystals and then
to provide evidences for a suitable remedy and personalized
treatment to urolithiasis in clinic.
4. Conclusion
The composition and morphology of nanocrystals in urines
of healthy persons and lithogenic patients were compar-
a t i v e l yi n v e s t i g a t e db ym e a n so fX R Da n dT E M .X R D
patterns showed that the urinary nanocrystals mainly were
COD, uric acid, and magnesium ammonium phosphate inBioinorganic Chemistry and Applications 7
healthy persons; but mainly were magnesium ammonium
phosphate, β-tricalcium phosphate, COD, and COM in
lithogenic patients. Especially the amount of COD crystals
in healthy urine was much more than that in lithogenic
urine. Based on the XRD diﬀraction data, the size of urinary
nanocrystalswasﬁguredouttobe23∼72nminhealthyurine
and about 12∼118nm in lithogenic patients, respectively,
by means of Scherer formula. TEM results showed that the
nanocrystals in healthy urine were dispersive and uniform
with an average size of about 38nm. In contrast, the
nanocrystals in lithogenic urine were much aggregated with
an average size of about 55nm. It was consistent with the
resultscalculatedfromXRDdata.Theresultsshowedthatthe
urinary stone formation may be prevented by diminishing
the size diﬀerentiation and the aggregation of nanocrystals
in urine through physical or chemical methods.
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